Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Levolin synchrobreathe Inhaler

Generic: Levosalbutamolby Cipla Limited

Buy Levolin synchrobreathe Inhaler (Levosalbutamol) online | SafeRxPills

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Levolin Inhaler (Levosalbutamol) online | SafeRxPills

Levolin Inhaler

$27.50View
Buy Levolin 0.63mg Respules (Levosalbutamol) online | SafeRxPills

Levolin 0.63mg Respules

$13.00View
Buy Levolin 1mg (Levosalbutamol) online | SafeRxPills

Levolin 1mg

$9.00View
Buy Levolin 2mg (Levosalbutamol) online | SafeRxPills

Levolin 2mg

$12.00View

About Levolin synchrobreathe Inhaler

Levolin Synchrobreathe is Cipla's levosalbutamol reliever in a breath actuated inhaler. Instead of pressing the canister while you breathe in, you open the mouthpiece cover and breathe in, and the device fires the puff for you. Cipla's prescribing information gives each actuation as levosalbutamol 50 mcg (as the tartrate) in HFA 134a propellant, with 120 metered doses per inhaler. Levosalbutamol is called levalbuterol in the US, where the brand is Xopenex HFA; it is the (R) half of ordinary salbutamol (albuterol). We sell single inhalers and packs of 3, 6 and 12, from $10.83 an inhaler before shipping in the 12 pack.

Two things to know before you buy. First, the medicine is the same as in Cipla's standard Levolin Inhaler; what you pay extra for is the device, and with 120 puffs instead of 200, each puff costs about twice as much or more (see the price table). Second, a reliever alone is not asthma treatment. GINA 2026 says adults, adolescents and children aged 6 to 11 with asthma "should not be treated with SABA alone. They should all receive ICS-containing treatment" (SABA is a short acting reliever like levosalbutamol; ICS is an inhaled steroid). If this is the only inhaler you use for asthma, ask a doctor about a preventer.

We found no published study of levosalbutamol given through the Synchrobreathe (PubMed search, 19 November 2026), and no study comparing Levolin Synchrobreathe with Xopenex HFA. The clinical facts on this page come from the US Xopenex HFA label and Cipla's own prescribing information, which uses the same dose.

Levolin Synchrobreathe at a glance

Active ingredientLevosalbutamol (levalbuterol) 50 mcg per actuation, as levosalbutamol tartrate, HFA 134a propellant, absolute alcohol 7.4% v/v (Cipla prescribing information)
Brand and makerLevolin Synchrobreathe, made by Cipla Ltd, Mumbai, India (Cipla; MediBuddy and Apollo listings)
DeviceBreath actuated pressurised inhaler with a dose counter, 120 metered doses (Cipla; carton in our product photo; Apollo, Medkart and SastaSundar listings)
Regulatory statusLevalbuterol inhalers are FDA approved in the US (Xopenex HFA and a generic). We found no levosalbutamol product licensed in the UK or Canada and could not confirm one in Australia. This Indian pack is not registered with the FDA, MHRA, TGA or Health Canada
Usual dose from the labelsCipla and US Xopenex HFA, age 4 and over: 2 inhalations repeated every 4 to 6 hours; in some people 1 inhalation every 4 hours may be sufficient. "More frequent administration or a larger number of inhalations is not routinely recommended."
TimingUS Xopenex HFA trials, ages 12 and over: median onset 5.5 to 10.2 minutes and median peak effect 76 to 78 minutes on day 1. US label: the action "should last for 4 to 6 hours". We found no timing data for the Synchrobreathe device itself
Packs1, 3, 6 and 12 inhalers
Price per inhaler$18.00 (single) down to $10.83 (12 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per inhaler and per puff

Prices are as of November 2026; the pack selector shows the current price.

PackPricePer inhalerPer puff (120 a canister)ShippingPer inhaler with shipping
1 inhaler$18$18.00$0.15$25$43.00
3 inhalers$40$13.33$0.11$25$21.67
6 inhalers$70$11.67$0.10$25$15.83
12 inhalers$130$10.83$0.09$25$12.92

Every pack is below the $149 free shipping line, so each one carries $25 shipping. The bigger packs are cheaper per inhaler before shipping as well. A single inhaler with shipping comes to $43, which is poor value; if you only need one, the 3 pack costs $22 more and gives you two spares.

Against the standard Levolin Inhaler. Levolin Inhaler holds 200 puffs and costs $7.92 to $9.17 an inhaler before shipping, about 4 to 5 cents a puff. Levolin Synchrobreathe works out at about 9 to 15 cents a puff before shipping. That is our arithmetic from our own prices. If you can use a press and breathe inhaler well, or with a spacer, the standard inhaler is the cheaper way to buy the same medicine.

How long one lasts. A new Synchrobreathe needs 2 test puffs, leaving 118. At the most the labels routinely allow, 2 puffs every 4 hours (12 a day), that is about 10 days; at 2 puffs twice a week it is close to 7 months. Again, these are our estimates, not label figures. GINA 2026 links 3 or more 200 dose reliever canisters dispensed in a year (600 puffs) with more severe attacks, and 12 or more (2,400 puffs, "possibly less") with a higher risk of dying from asthma. With 120 puff canisters, those levels are about 5 and 20 Synchrobreathe inhalers a year (our arithmetic). If you get through more than a few a year, the answer is a review of your preventer, not a bigger pack.

Compared with US levalbuterol and albuterol inhalers

Levolin Synchrobreathe (ours)US generic levalbuterol HFAXopenex HFAUS generic albuterol HFA
MakerCipla, IndiaActavisLupinTeva, Hikma, Lupin, Amneal, Cipla USA and others
How you fire itBreathing in releases the puffPress the canister while breathing inPress the canister while breathing inPress the canister while breathing in
Puffs per inhaler120200200200
Registered with the FDANo (this Indian pack)YesYesYes
Cost per puff$0.09 to $0.15 before shipping; $0.11 to $0.36 with shippingAbout $0.27 (NADAC)About $0.37 (NADAC)About $0.06 to $0.17 (NADAC)

NADAC is the price US pharmacies pay to buy the medicine, not what you pay at the counter. NADAC lists these inhalers per gram; the rates effective 18 November 2026 are $3.60996 a gram for generic levalbuterol HFA and $4.98300 a gram for Xopenex HFA, both 15 g canisters of 200 puffs (about $54.15 and $74.75 an inhaler), and $1.49523 to $2.09106 a gram for generic albuterol HFA, which comes to about $12.71 to $33.01 per 200 puff canister once multiplied by each canister's fill weight. The per puff figures are our arithmetic. We compare per puff because the labelled dose of every product in the table is 2 puffs.

The plain reading: per puff, our Synchrobreathe packs cost less than US pharmacies pay for levalbuterol, but generic albuterol inhalers cost US pharmacies about the same or less per puff, and the US Xopenex HFA label makes no claim that levalbuterol works better than albuterol. If you are in the US and have a prescription or insurance, ask your doctor whether a generic albuterol inhaler (with a spacer if needed) would do the job, and check your copay first. The evidence on the two forms of salbutamol is in our salbutamol vs levosalbutamol guide.

Synchrobreathe or a standard inhaler: what actually changes

Both are pressurised metered dose inhalers (Lavorini 2023 describes the Synchrobreathe as a breath actuated pressurised metered dose inhaler), and Cipla's prescribing information gives the same 50 mcg per actuation for Levolin Synchrobreathe and Levolin Inhaler. The differences are in how you use and look after them. The Synchrobreathe column below is from Cipla's Levolin Synchrobreathe instructions; the standard column is from the US Xopenex HFA instructions.

Levolin SynchrobreatheStandard levalbuterol inhaler (US label)
Releasing a puffWith the cover open, breathing in through the mouthpiece fires the puff; closing the cover prepares the next oneYou press the canister as you start to breathe in
Before first useShake and test fire 2 puffs into the air if new or not used for a week or more4 test sprays if new or not used for more than 3 days
Puffs120200
Dose counterCounts every puff but shows 120, 100, 80 and so on in steps of 20; turns from green to red at 40Dose indicator counting down from 200 (the US label says it moves every tenth actuation; its Instructions for Use say every 20 sprays); red when about 20 inhalations are left; discard at 0. The correct amount "cannot be assured after 200 actuations, even though the canister is not completely empty"
CleaningWipe the mouthpiece with a dry cloth once a week; "should NEVER be washed"Wash the plastic actuator in warm water at least once a week (the US label calls this "critical")
Storage"Store below 30°C", do not freeze20 to 25°C, protect from freezing

The washing rule is the one people get wrong when they switch. Water damages the Synchrobreathe's working parts, so never rinse it the way you would rinse a standard actuator.

What the device evidence shows. Cipla says the device is triggered at a low breathing in flow; its technical dossier, written around another Synchrobreathe product, gives "approximately 23 to 35 L/min". The studies on breath actuated inhalers are about handling, not about levosalbutamol:

  • A French observational study of 3,811 primary care patients (Molimard 2003) found errors that would compromise treatment in 28% of people using a standard pressurised inhaler, against 11% to 12% with an Autohaler (another breath actuated inhaler), Aerolizer or Diskus.
  • An open label, 2 week Indian study of 460 people (Balamurugan 2020, three of whose authors work for Cipla) compared the Synchrobreathe with a standard inhaler. On day 1, after reading the leaflet alone, significantly fewer people used the Synchrobreathe without any error; after training, and by day 14, the Synchrobreathe came out ahead on errors and attempts. Read it as: the device is easy once someone shows you how, not that the leaflet is enough.
  • A 2023 narrative review (Lavorini, three of whose authors work for Cipla) reports 68.19% error free use with the Synchrobreathe against 56.21% with a standard inhaler.

GINA 2026 asks prescribers to choose the device as well as the medicine, considering "physical problems such as arthritis, the patient's skills, and cost". A breath actuated inhaler can suit people who cannot time the press with the breath, or whose hands struggle with pressing a canister. A standard inhaler with a spacer is the usual alternative, and it is cheaper.

Which Levolin form to choose

ProductWhat it isWhen it fits
Levolin Synchrobreathe (this page)Breath actuated inhaler, 50 mcg per actuation, 120 puffsPeople who struggle to coordinate a press and breathe inhaler
Levolin InhalerStandard pressurised inhaler, same 50 mcg labelled dose, 200 puffsMost people, with a spacer if timing is hard; cheaper per puff
Levolin 0.63mg RespulesNebuliser solutionOnly with a nebuliser on a doctor's plan; GINA 2026 links home use of nebulised SABA with a higher risk of asthma death
Levolin 1mg and Levolin 2mg tabletsOral levosalbutamolNot a reliever for attacks; we would not recommend them (the Levolin 2mg page explains why)
Asthalin InhalerCipla's salbutamol (racemic) inhaler, 100 mcg a puffThe ordinary salbutamol option, from $8.33 an inhaler before shipping. Use one reliever, not two
Foracort 200 SynchrobreatheBudesonide with formoterol, a preventer, in the same deviceOnly if a doctor has prescribed it; it is a different medicine, not another version of Levolin

How to use Levolin Synchrobreathe

Dose. Cipla and the US label give the same dose for adults and children aged 4 and over: 2 inhalations every 4 to 6 hours, or in some people 1 inhalation every 4 hours. Do not take more puffs or take them more often unless your doctor has told you to. Follow your written asthma action plan.

Steps (Cipla's instructions for this device, in our words; read the leaflet in the pack too):

  1. Shake and open. Hold the inhaler sideways with your fingers clear of the mouthpiece cover and of the dose release button at the back. Shake it well with the cover closed, then open the cover gently by the grooves on its sides. Do not flip it down from the top or snap it open quickly: Cipla says forcing it open can release a dose.
  2. Breathe. Sit or stand and hold the inhaler upright. Put the mouthpiece between your teeth and close your lips around it without biting. Breathe in slowly and deeply. The puff fires on its own as you start to breathe in, with a click and a whoosh. Keep breathing in after you hear it.
  3. Hold and close. Take the inhaler out, hold your breath for 10 seconds or as long as is comfortable, then breathe out slowly. Close the cover straight away with the inhaler upright; closing it is what sets the next puff.
  4. For a second puff, repeat steps 1 to 3.

Test firing. Only for a new inhaler or one unused for a week or more: shake, open, point the mouthpiece away from you, press the dose release button at the back, close. Do this twice. The back button is only for test firing, never for taking a dose.

When it is empty. Get a new one before the counter reaches 0. Cipla says the inhaler may not feel empty and may keep working after 0, but you will not get the right amount of medicine. Do not drop it, pull it apart, poke anything into it or tamper with the counter. It is pressurised: never puncture or burn it, even when empty, and keep it away from heat and direct sunlight.

Children should use it with an adult's help (Cipla). Cipla's patient section also tells users to rinse their mouth after each dose to lower the chance of thrush. Cipla's patient section also lists thrush among the side effects. That text matches steroid inhaler leaflets; levosalbutamol is not a steroid and the US label has no thrush warning (our reading). Rinsing does no harm, so follow Cipla's advice.

Storage. Cipla says store below 30°C and do not freeze. Indian listings say room temperature (Medkart), 20 to 25°C (Apollo) or below 30°C (SastaSundar). It does not need a fridge.

Groups who need extra care

  • Under 4 years: Cipla says safety and effectiveness below age 4 "have not been established"; the US label says levalbuterol is not indicated under 4.
  • Heart disease, high blood pressure or an irregular heartbeat: use with caution (US label 5.4 and 5.7; Cipla says the same). Beta agonists can raise heart rate and blood pressure in some people.
  • Seizures, an overactive thyroid or diabetes: use with caution (US 5.7, Cipla).
  • Low potassium: it "may produce significant hypokalemia in some patients", usually short lived (US 5.8, Cipla).
  • Aged 65 and over: dose selection should be cautious, usually starting at the low end of the dose range (US 8.5, Cipla).
  • Kidney problems: salbutamol is substantially cleared by the kidneys; the US label advises caution with high doses in kidney impairment.
  • Pregnancy: Cipla says it "should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus". Cipla adds that poorly or moderately controlled asthma raises the risk of pre-eclampsia and of premature or small babies, so do not stop asthma treatment without advice. It is not approved for stopping preterm labour.
  • Breastfeeding: it is not known whether levosalbutamol passes into breast milk (Cipla). Cipla's patient section says you and your doctor should decide.

Medicines that interact (Cipla's prescribing information, matching US label section 7):

  • Other short acting relievers or adrenaline (epinephrine) "should not be used concomitantly". That covers salbutamol inhalers such as Asthalin and, on our reading, combination products that contain salbutamol or levosalbutamol.
  • Beta blockers can block its effect and "may produce severe bronchospasm in asthmatic patients"; people with asthma "should not normally be treated with beta-blockers". If one is essential, for example after a heart attack, cardioselective beta blockers "should be considered, although they should be administered with caution".
  • Non potassium sparing diuretics (loop or thiazide water tablets): low potassium and ECG changes can get worse; consider checking potassium.
  • Digoxin: racemic salbutamol lowered digoxin levels by 16% to 22% in volunteers; digoxin levels should be checked.
  • MAO inhibitors or tricyclic antidepressants, now or in the last 2 weeks: only "with extreme caution"; Cipla says consider another treatment.

Side effects

The figures come from the standard Xopenex HFA inhaler; there are no side effect data for this device. In two 8 week US trials in people aged 12 to 81 with asthma, these reactions were reported in at least 2% of people on levalbuterol and more often than on placebo:

ReactionLevalbuterol 90 mcg (403)Albuterol 180 mcg (179)Placebo (166)
Asthma9%7%6%
Sore throat (pharyngitis)8%2%2%
Runny or blocked nose (rhinitis)7%2%3%
Pain4%3%4%
Dizziness3%1%2%

Source: US label Table 1, all rows. In children aged 4 to 11 (US Table 2), vomiting, accidental injury, sore throat and bronchitis were the reactions listed. Cipla's prescribing information gives the same lists without percentages and adds that "the incidence of systemic beta-adrenergic adverse effects (e.g., tremor, nervousness) was low". The US label lists palpitations, chest pain, a fast heart rate, tremor and nervousness as common effects of inhaled beta agonists (section 17), and high blood pressure, angina, vertigo, sleeplessness, headache and a dry or irritated throat as class effects (6.2). Reports after approval of the levalbuterol nebuliser solution include angioedema, anaphylaxis, irregular heart rhythms such as atrial fibrillation and metabolic acidosis, with no reliable frequency (6.2).

When to get urgent help

  • A severe asthma attack, or breathing that is not better after your reliever: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia). The US Patient Information says to go to the nearest hospital emergency room right away if you have worsening lung symptoms.
  • Wheezing or breathlessness that gets worse straight after a puff (paradoxical bronchospasm): stop using it and get emergency help. The US label says this "may be life-threatening" and "frequently occurs with the first use of a new canister".
  • The inhaler helping less than usual, or needing it more often than usual: the US label says to "seek medical attention immediately".
  • Chest pain, a very fast or irregular heartbeat, fainting or a seizure: get emergency help (our advice; the US Patient Information lists heart problems as a serious side effect).
  • Swelling of the face, throat or tongue, hives, rash or breathing problems: possible allergy. The US Patient Information says stop using it and call your doctor right away; call emergency services if breathing or swallowing is affected (our advice).
  • Too many puffs: Cipla says call your healthcare provider or go to the nearest emergency room right away if you have unusual symptoms such as worsening breathlessness, chest pain, a faster heart rate or shakiness. Tell staff what you took, how many puffs and when.

Who should not use it

Never use it if you are allergic to levosalbutamol or any ingredient of the inhaler (Cipla; the US label also names racemic albuterol). Reactions have included hives, angioedema, rash, bronchospasm, anaphylaxis and swelling in the mouth and throat.

The labels advise against or limit use:

  • Alongside another short acting reliever or adrenaline: "should not be used concomitantly" (Cipla, US 7).
  • In children under 4: not established (Cipla); not indicated (US).
  • As your only asthma treatment: the US label says a beta agonist alone "may not be adequate to control asthma in many patients", and GINA 2026 says SABA alone should not be used for asthma.
  • In people on MAO inhibitors or tricyclic antidepressants: only with extreme caution (Cipla, US 7.4).

Prescription and legal status

  • US: levalbuterol inhalers are prescription only (the Xopenex HFA Patient Information calls it "an inhaled prescription medicine"). The FDA says personal importation of medicines is "illegal in most circumstances".
  • UK: we found no MHRA licensed levosalbutamol product. The UK does license a breath actuated salbutamol reliever, Salamol Easi-Breathe (Teva, 100 micrograms a puff, 200 doses), as a prescription only medicine.
  • Australia: we could not confirm an ARTG listing for levosalbutamol. The Poisons Standard covers every stereoisomer of a listed substance, and salbutamol as the only active ingredient is Schedule 3 in metered aerosols delivering 100 micrograms or less per dose (and some dry powder inhalers), otherwise Schedule 4.
  • Canada: the Health Canada Drug Product Database lists no levalbuterol or levosalbutamol product (searched 19 November 2026).
  • India: sold on prescription (Apollo "Prescription drug", Medkart "Prescription Required", SastaSundar "Doctor's Note Required").

Buying genuine Levolin Synchrobreathe

Check that the carton says Cipla and 120 metered doses, that the batch number and expiry on the carton match the inhaler, and that the counter reads 120 when new. These checks help, but they cannot prove an inhaler is genuine. The MHRA's warning covers this product too: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It advises UK buyers: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". If an inhaler seems not to work, or causes symptoms, get medical advice and report it to the MHRA Yellow Card scheme, FDA MedWatch, the TGA or Health Canada, as well as to us. A reliever that fails during an attack is an emergency: use another reliever if you have one and call emergency services.

Delivery

Orders reach the US, UK, Australia and Canada in 7 to 14 business days, in plain packaging with tracking. Shipping is $25 on orders under $149 and free from $149. That timescale means this is not a way to get a reliever quickly: keep a spare at home before the current one runs low.

Related guides

Sources

  • Cipla Ltd. LEVOLIN Synchrobreathe prescribing information and patient counselling information (composition, dosage, contraindications, warnings, interactions, special populations, undesirable effects, instructions for use, storage, 120 metered doses). Date of revision May 2022. CiplaMed, accessed 19 November 2026.
  • Xopenex HFA (levalbuterol tartrate) inhalation aerosol, US prescribing information, Patient Information and Instructions for Use, Lupin. DailyMed setid 70a35706-d7a8-4a48-98c6-1cab1c42fe8d, version 3 (30 July 2025): sections 1, 2, 4, 5.1 to 5.8, 6.1 (Tables 1 and 2), 6.2, 7, 8.1 to 8.6, 12.2, 14.1, 16, 17.
  • Global Initiative for Asthma. GINA 2026 Summary Guide (SABA alone, canister thresholds, nebulised SABA, device choice).
  • NADAC (data.medicaid.gov), rows effective 18 November 2026: NDC 00591292754 levalbuterol HFA, 27437005601 Xopenex HFA, 12 albuterol HFA NDCs; canister fill weights from the US labels.
  • Molimard M, et al. Assessment of handling of inhaler devices in real life. J Aerosol Med 2003. PMID 14572322.
  • Balamurugan S, et al. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe, versus a pMDI. Respir Med 2020. PMID 32056719.
  • Lavorini F, et al. A narrative review on the Synchrobreathe. Respir Med 2023. PMID 38652077.
  • Cipla. Synchrobreathe technical dossier (trigger flow). CiplaMed, accessed October 2026.
  • Salamol Easi-Breathe CFC-Free Inhaler, UK SmPC, Teva UK. emc 2070, last updated 8 April 2026.
  • MHRA Products database (levosalbutamol search, October 2026); Health Canada Drug Product Database (19 November 2026); Therapeutic Goods (Poisons Standard, October 2026) Instrument 2026, F2026L01327.
  • MHRA news release, 13 February 2026; FDA personal importation guidance.
  • Indian listings: Apollo Pharmacy, Medkart, SastaSundar, MediBuddy (accessed 19 November 2026).

Frequently asked questions

What is Levolin Synchrobreathe?

It is Cipla's levosalbutamol (levalbuterol) reliever inhaler in a breath actuated device. Cipla's prescribing information gives 50 mcg per actuation and 120 metered doses. Instead of pressing a canister, you open the mouthpiece cover and breathe in, and the inhaler releases the puff. It relaxes tightened airways in asthma and similar conditions; it is a reliever, not a preventer.

Is it the same medicine as Levolin Inhaler or Xopenex HFA?

Cipla gives the same 50 mcg per actuation and the same dose for Levolin Synchrobreathe as for its standard Levolin Inhaler; the difference is the device and the number of puffs (120 against 200). Xopenex HFA is the US levalbuterol inhaler, which the US label describes as delivering 45 mcg from the mouthpiece. We have not found a published study comparing Levolin Synchrobreathe with Xopenex HFA, and this Indian pack is not registered with the FDA, MHRA, TGA or Health Canada.

How much does it cost per inhaler and per puff?

As of November 2026: $18 for one, $40 for 3 ($13.33 each), $70 for 6 ($11.67 each) and $130 for 12 ($10.83 each), before $25 shipping, which applies to every pack because all are under $149. That is about 9 to 15 cents a puff before shipping, about twice or more the per puff cost of our standard Levolin Inhaler, pack for pack (our arithmetic). The pack selector shows the current price.

How do I use a Synchrobreathe?

Following Cipla's instructions: hold it sideways with fingers clear of the cover and the back button, shake it with the cover closed, then open the cover gently. Hold it upright, seal your lips around the mouthpiece and breathe in slowly and deeply; it fires with a click as you start to breathe in, so keep breathing in. Hold your breath for 10 seconds, or as long as is comfortable, breathe out, and close the cover straight away. Repeat for a second puff. Test fire 2 puffs into the air only if it is new or unused for a week or more.

What dose should I take?

Cipla and the US Xopenex HFA label give, for adults and children aged 4 and over, 2 inhalations every 4 to 6 hours, or in some people 1 inhalation every 4 hours. Both say more frequent use or more inhalations is not routinely recommended. Use the dose on your prescription or asthma action plan.

How quickly does it work and how long does it last?

In the US Xopenex HFA trials in people aged 12 and over, median onset was 5.5 to 10.2 minutes and median peak effect 76 to 78 minutes on day 1, and the US label says the action should last 4 to 6 hours. These figures come from the standard press and breathe inhaler; we found no timing data for the Synchrobreathe device itself.

Can I wash it like a normal inhaler?

No. Cipla says the Synchrobreathe should never be washed and must always be kept dry. Wipe the mouthpiece once a week with a clean dry cloth or tissue, and do not push anything into the device. This is the opposite of the US standard inhaler instructions, which ask you to wash the plastic actuator weekly.

What are the side effects?

In two 8 week US trials of the standard levalbuterol inhaler in people aged 12 and over, reactions in at least 2% and more often than placebo were asthma (9% vs 6%), sore throat (8% vs 2%), runny or blocked nose (7% vs 3%), pain and dizziness. Beta agonists can also cause a fast heartbeat, palpitations, tremor and nervousness. Wheezing that gets worse right after a puff can be life threatening: stop and get emergency help.

Who should not use it?

Anyone allergic to levosalbutamol or any ingredient of the inhaler (the US label also names racemic albuterol). The labels say it should not be used together with other short acting relievers or adrenaline, safety is not established under age 4, and it needs caution with heart disease, seizures, an overactive thyroid, diabetes, low potassium, diuretics and digoxin. People with asthma should not normally take beta blockers, and it should be used only with extreme caution with MAO inhibitors or tricyclic antidepressants. It should not be anyone's only asthma treatment.

Do I need a prescription?

In the US, levalbuterol inhalers are prescription medicines, and the FDA says personal importation is illegal in most circumstances. We found no levosalbutamol product licensed in the UK or Canada and could not confirm one in Australia. Indian pharmacy listings sell Levolin Synchrobreathe on prescription. Your doctor should be managing your asthma, including a preventer.

How long does delivery take?

7 to 14 business days to the US, UK, Australia and Canada, in plain packaging with tracking. Shipping is $25 under $149 and free from $149. Because of that wait, order well before your current inhaler runs out, and never rely on a delivery during an attack.

Medical References

  1. 1.LEVOLIN Synchrobreathe prescribing information and patient counselling information, Cipla Ltd (date of revision May 2022) — 2022
  2. 2.XOPENEX HFA (levalbuterol tartrate) inhalation aerosol, US prescribing information, Patient Information and Instructions for Use, Lupin Pharmaceuticals (DailyMed SPL version 3) — 2025
  3. 3.Global Initiative for Asthma. GINA 2026 Summary Guide for Asthma Management and Prevention — 2026
  4. 4.CMS National Average Drug Acquisition Cost (NADAC): levalbuterol tartrate HFA, Xopenex HFA and albuterol HFA per gram, effective 18 November 2026 — 2026
  5. 5.Molimard M, et al. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003 (PMID: 14572322) — 2003
  6. 6.Balamurugan S, et al. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe, versus a pMDI. Respir Med 2020 (PMID: 32056719) — 2020
  7. 7.Lavorini F, et al. A narrative review on the Synchrobreathe: a novel breath-actuated pressurised metered-dose inhaler. Respir Med 2023 (PMID: 38652077) — 2023
  8. 8.Cipla. Synchrobreathe technical dossier
  9. 9.Salamol Easi-Breathe CFC-Free Inhaler, Summary of Product Characteristics, Teva UK (emc, last updated 8 April 2026) — 2026
  10. 10.Therapeutic Goods (Poisons Standard October 2026) Instrument 2026, F2026L01327 — 2026
  11. 11.Health Canada Drug Product Database (searched 19 November 2026)
  12. 12.MHRA Products database (searched October 2026)
  13. 13.MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys — 2026
  14. 14.US Food and Drug Administration. Personal Importation
  15. 15.Apollo Pharmacy. Levolin Synchrobreathe Inhaler 120 mdi (Cipla) listing, accessed November 2026
  16. 16.SastaSundar. Levolin Synchrobreathe 7.2 g (120 Metered Doses) listing, accessed November 2026

Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA

Guide to AsthmaHow asthma medicines actually work: relievers, inhaled steroids, combination inhalers and leukotriene tablets, with the 2019 guideline change that ended reliever-only treatment.

Related articles

Customer Reviews

No reviews yet. Bought Levolin synchrobreathe Inhaler? Tell other buyers how it went.